Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Repaglinide products are in shortage in Canada (6 of 21 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 4, 2026.
A diabetes medication used to lower blood sugar after meals in type 2 diabetes.
Products affected
6 / 21
In shortage since
Nov 1, 2021
Est. full return
Sep 4, 2026
Reports on file
54
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP REPAGLINIDE
2MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354942 · since Oct 31, 2025, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP REPAGLINIDE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354934 · since Oct 31, 2025, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP REPAGLINIDE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354926 · since Oct 31, 2025, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACT REPAGLINIDE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02321491 · since Nov 16, 2021, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACT REPAGLINIDE
1MG · TABLET · TEVA CANADA LIMITED
DIN 02321483 · since Nov 1, 2021, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACT REPAGLINIDE
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02321475 · since Nov 1, 2021, no end estimate · Disruption of the manufacture of the drug.
Resolved
JAMP REPAGLINIDE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354934 · ended Sep 19, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP REPAGLINIDE
2MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354942 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP REPAGLINIDE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02354926 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
Resolved
AURO-REPAGLINIDE
1MG · TABLET · AURO PHARMA INC
DIN 02424266 · ended Nov 15, 2024 · Demand increase for the drug.
Resolved
REPAGLINIDE
2MG · TABLET · PRO DOC LIMITEE
DIN 02415984 · ended Oct 18, 2024 · Delay in shipping of the drug.
Resolved
REPAGLINIDE
0.5MG · TABLET · PRO DOC LIMITEE
DIN 02415968 · ended Oct 18, 2024 · Delay in shipping of the drug.
Showing 12 of 54 reports. All reports are on file with Health Canada.
What's happening
Repaglinide is currently affected by 6 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Repaglinide is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BX).
Recent changes
No changes recorded yet.
Common questions
What is Repaglinide used for?
A diabetes medication used to lower blood sugar after meals in type 2 diabetes.
When will Repaglinide be back in stock in Canada?
The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Repaglinide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.